 |
BioWorld-International-2010-05-26
Idebenone at 'Deadend' with Second Pivotal Trial Failure
TPP Raises $13.8M to Collect Pharma-Pleasing Compounds
LONDON – TPP Global Development has raised £9.6 million (US$13.8 million) to fund early preclinical development of programs in-licensed from universities and public research institutes, to meet the standards required by pharma. (BioWorld International)